High Vista Strategies LLC Vera Therapeutics, Inc. Transaction History
High Vista Strategies LLC
- $242 Million
- Q4 2024
A detailed history of High Vista Strategies LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 52,197 shares of VERA stock, worth $1.5 Million. This represents 0.91% of its overall portfolio holdings.
Number of Shares
52,197
Previous 22,010
137.15%
Holding current value
$1.5 Million
Previous $972,000
127.06%
% of portfolio
0.91%
Previous 0.38%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$162 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$126 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$96.2 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$85.3 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$85 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $779M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...